PLGA nanocapsules as a delivery system for a recombinant LRP‐based therapeutic
PLGA nanocapsules as a delivery system for a recombinant LRP‐based therapeutic
About this item
Full title
Author / Creator
Publisher
England: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
England: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Telomerase activity is directly affected by the laminin receptor precursor (LRP) protein, a highly conserved nonintegrin transmembrane receptor, which has been shown to have therapeutic effects in ageing, and age‐related diseases. Recently, it has been found that overexpression of LRP‐FLAG, by plasmid transfection, leads to a significant increase i...
Alternative Titles
Full title
PLGA nanocapsules as a delivery system for a recombinant LRP‐based therapeutic
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_c5bbe0960aa9461e83bd2e9280259f19
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c5bbe0960aa9461e83bd2e9280259f19
Other Identifiers
ISSN
2211-5463
E-ISSN
2211-5463
DOI
10.1002/2211-5463.13809
